All in due time,Lets see if PS takes the adviceYesterdays AGM outcome did the job,I would say PS's work has been doneTHE HAMMER
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%